Pentobarbital will decrease the level or effect of fentanyl transmucosal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Profesor Closely. Coadministration of fentanyl with CYP3A4 inducers could lead to a decrease in fentanyl plasma concentrations, lack of efficacy or, possibly, development of a withdrawal syndrome in a patient who has developed https://elpentobarbitalesuntipode09742.blogdon.net/cuáles-son-las-alternativas-al-pentobarbital-fundamentos-explicación-46277614